Rapid β-oxidation of eicosapentaenoic acid in mouse brain: An in situ study

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 2-3, 2009, Pages 157-163

  Chen, Chuck T ^a   Liu, Zhen ^a   Ouellet, Melissa ^b   Calon, Frédéric ^b   Bazinet, Richard P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

oxidation; Brain; Eicosapentaenoic acid; In situ cerebral perfusion; Mouse; Polyunsaturated fatty acid; Transport

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; C57BL 6 MOUSE; FATTY ACID ANALYSIS; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CHOLESTEROL ESTERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; LIPID METABOLISM; LIPIDS; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; PERFUSION; PHOSPHOLIPIDS; TRIGLYCERIDES;

MUS;

EID: 62149092899     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.01.005     Document Type: Article

References (79)

1. Scott B.L., and Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. USA 86 (1989) 2903-2907
2. Cunnane S.C. Problems with essential fatty acids: time for a new paradigm?. Prog. Lipid Res. 42 (2003) 544-568
3. Voss A., Reinhart M., Sankarappa S., and Sprecher H. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J. Biol. Chem. 266 (1991) 19995-20000
4. Serhan C.N., Clish C.B., Brannon J., et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192 (2000) 1197-1204
5. Serhan C.N., Clish C.B., Brannon J., et al. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions. J. Physiol. Pharmacol. 51 (2000) 643-654
6. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196 (2002) 1025-1037
7. Black K.L., Hoff J.T., Radin N.S., and Deshmukh G.D. Eicosapentaenoic acid: effect on brain prostaglandins, cerebral blood flow and edema in ischemic gerbils. Stroke 15 (1984) 65-69
8. Song C., Manku M.S., and Horrobin D.F. Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats. J. Nutr. 138 (2008) 954-963
9. Song C., Phillips A.G., Leonard B.E., and Horrobin D.F. Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats. Mol. Psychiatry 9 (2004) 630-638
10. Kew S., Wells S., Thies F., et al. The effect of eicosapentaenoic acid on rat lymphocyte proliferation depends upon its position in dietary triacylglycerols. J. Nutr. 133 (2003) 4230-4238
11. Miles E.A., Banerjee T., Dooper M.M., et al. The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br. J. Nutr. 91 (2004) 893-903
12. Peterson L.D., Jeffery N.M., Thies F., et al. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 33 (1998) 171-180
13. Thies F., Nebe-von-Caron G., Powell J.R., et al. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am. J. Clin. Nutr. 73 (2001) 539-548
14. Adan Y., Shibata K., Sato M., Ikeda I., and Imaizumi K. Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats. Biosci. Biotechnol. Biochem. 63 (1999) 111-119
15. Ahmed A.A., and Holub B.J. Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod-liver oil. Lipids 19 (1984) 617-624
16. Nieuwenhuys C.M., and Hornstra G. The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats. Biochim. Biophys. Acta 390 (1998) 313-322
17. Park Y., and Harris W. EPA, but not DHA, decreases mean platelet volume in normal subjects. Lipids 37 (2002) 941-946
18. Turini M.E., Powell W.S., Behr S.R., and Holub B.J. Effects of a fish-oil and vegetable-oil formula on aggregation and ethanolamine-containing lysophospholipid generation in activated human platelets and on leukotriene production in stimulated neutrophils. Am. J. Clin. Nutr. 60 (1994) 717-724
19. Black K.L., Hsu S., Radin N.S., and Hoff J.T. Effect of intravenous eicosapentaenoic acid on cerebral blood flow, edema and brain prostaglandins in ischemic gerbils. Prostaglandins 28 (1984) 545-556
20. Katayama Y., Katsumata T., Muramatsu H., et al. Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP). Brain Res. 761 (1997) 300-305
21. Katsumata T., Katayama Y., Obo R., et al. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur. J. Pharmacol. 372 (1999) 167-174
22. Chen C.T., Ma D.W., Kim J.H., Mount H.T., and Bazinet R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J. Lipid. Res. 49 (2008) 147-152
23. DeMar Jr. J.C., DiMartino C., Baca A.W., Lefkowitz W., and Salem Jr. N. Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats. J. Lipid. Res. 49 (2008) 1963-1980
24. Philbrick D.J., Mahadevappa V.G., Ackman R.G., and Holub B.J. Ingestion of fish oil or a derived n-3 fatty acid concentrate containing eicosapentaenoic acid (EPA) affects fatty acid compositions of individual phospholipids of rat brain, sciatic nerve and retina. J. Nutr. 117 (1987) 1663-1670
25. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J. Mol. Neurosci. 16 (2001) 181-193 (Discussion 215-121)
26. Spector A.A. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J. Mol. Neurosci. 16 (2001) 159-165 (Discussion 215-121)
27. Hamilton J.A., and Brunaldi K. A model for fatty acid transport into the brain. J. Mol. Neurosci. 33 (2007) 12-17
28. Hamilton J.A., Johnson R.A., Corkey B., and Kamp F. Fatty acid transport: the diffusion mechanism in model and biological membranes. J. Mol. Neurosci. 16 (2001) 99-108 discussion 151-107
29. Rapoport S.I., Chang M.C., and Spector A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42 (2001) 678-685
30. Edmond J., Higa T.A., Korsak R.A., Bergner E.A., and Lee W.N. Fatty acid transport and utilization for the developing brain. J. Neurochem. 70 (1998) 1227-1234
31. Innis S.M., Sprecher H., Hachey D., Edmond J., and Anderson R.E. Neonatal polyunsaturated fatty acid metabolism. Lipids 34 (1999) 139-149
32. Marbois B.N., Ajie H.O., Korsak R.A., Sensharma D.K., and Edmond J. The origin of palmitic acid in brain of the developing rat. Lipids 27 (1992) 587-592
33. Igarashi M., DeMar Jr. J.C., Ma K., et al. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J. Lipid Res. 48 (2007) 1150-1158
34. Hanaka S., Abe T., Itakura H., and Matsumoto A. Gene expression related to cholesterol metabolism in mouse brain during development. Brain Dev. 22 (2000) 321-326
35. Hofmann S.L., Russell D.W., Goldstein J.L., and Brown M.S. mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. Proc. Natl. Acad. Sci. USA 84 (1987) 6312-6316
36. Meresse S., Delbart C., Fruchart J.C., and Cecchelli R. Low-density lipoprotein receptor on endothelium of brain capillaries. J. Neurochem. 53 (1989) 340-345
37. Lein E.S., Hawrylycz M.J., Ao N., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445 (2007) 168-176
38. Ricciarelli R., D'Abramo C., Zingg J.M., et al. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease. Free Radical Biol. Med. 36 (2004) 1018-1024
39. Kamp F., and Hamilton J.A. pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids. Proc. Natl. Acad. Sci. USA 89 (1992) 11367-11370
40. Kamp F., Zakim D., Zhang F., Noy N., and Hamilton J.A. Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry 34 (1995) 11928-11937
41. Demar Jr. J.C., Ma K., Chang L., Bell J.M., and Rapoport S.I. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94 (2005) 1063-1076
42. DeMar Jr. J.C., Lee H.J., Ma K., et al. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 1761 (2006) 1050-1059
43. Golovko M.Y., and Murphy E.J. Uptake and metabolism of plasma-derived erucic acid by rat brain. J. Lipid Res. 47 (2006) 1289-1297
44. Smith Q.R., and Nagura H. Fatty acid uptake and incorporation in brain: studies with the perfusion model. J. Mol. Neurosci. 16 (2001) 167-172 (Discussion 215-121)
45. Takasato Y., Rapoport S.I., and Smith Q.R. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247 (1984) H484-H493
46. Dagenais C., Rousselle C., Pollack G.M., and Scherrmann J.M. Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice. J. Cereb. Blood Flow Metab. 20 (2000) 381-386
47. Green J.T., Orr S.K., and Bazinet R.P. The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids. J. Lipid Res. 49 (2008) 939-944
48. Chen C.T., Green J.T., Orr S.K., and Bazinet R.P. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot. Essent. Fatty Acids 79 (2008) 85-91
49. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
50. Miller J.C., Gnaedinger J.M., and Rapoport S.I. Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways. J. Neurochem. 49 (1987) 1507-1514
51. Igarashi M., DeMar Jr. J.C., Ma K., et al. Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J. Lipid Res. 48 (2007) 152-164
52. Sublette M.E., Bosetti F., DeMar J.C., et al. Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord. 9 (2007) 759-765
53. Gavino G.R., and Gavino V.C. Rat liver outer mitochondrial carnitine palmitoyltransferase activity towards long-chain polyunsaturated fatty acids and their CoA esters. Lipids 26 (1991) 266-270
54. Oldendorf W.H., and Brown W.J. Greater number of capillary endothelial cell mitochondria in brain than in muscle. Proc. Soc. Exp. Biol. Med. 149 (1975) 736-738
55. Oldendorf W.H., Cornford M.E., and Brown W.J. The large apparent metabolic work capacity of the blood-brain barrier. Trans. Am. Neurol. Assoc. 101 (1976) 157-160
56. Oldendorf W.H., Cornford M.E., and Brown W.J. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann. Neurol. 1 (1977) 409-417
57. Stewart P.A., and Wiley M.J. Structural and histochemical features of the avian blood-brain barrier. J. Comp. Neurol. 202 (1981) 157-167
58. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., and Lee H.J. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol. Psychiatry 59 (2006) 401-407
59. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., and Lee H.J. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. Psychopharmacol. (Berl.) 182 (2005) 180-185
60. Lee H.J., Ghelardoni S., Chang L., et al. Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. Neurochem. Res. 30 (2005) 677-683
61. Ge L., Gordon J.S., Hsuan C., Stenn K., and Prouty S.M. Identification of the delta-6 desaturase of human sebaceous glands: expression and enzyme activity. J. Invest. Dermatol. 120 (2003) 707-714
62. Bourre J.M., and Piciotti M. Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse. Neurosci. Lett. 141 (1992) 65-68
63. Bourre J.M., Piciotti M., and Dumont O. Delta 6 desaturase in brain and liver during development and aging. Lipids 25 (1990) 354-356
64. Cunnane S.C., Ryan M.A., Lin Y.H., Lim S.Y., and Salem Jr. N. Suckling rats actively recycle carbon from alpha-linolenate into newly synthesized lipids even during extreme dietary deficiency of n-3 polyunsaturates. Pediatr. Res. 59 (2006) 107-110
65. Menard C.R., Goodman K.J., Corso T.N., Brenna J.T., and Cunnane S.C. Recycling of carbon into lipids synthesized de novo is a quantitatively important pathway of alpha-[U-13C]linolenate utilization in the developing rat brain. J. Neurochem. 71 (1998) 2151-2158
66. Taha A.Y., Ryan M.A., and Cunnane S.C. Markedly raised intake of saturated and monounsaturated fatty acids in rats on a high-fat ketogenic diet does not inhibit carbon recycling of 13C-alpha-linolenate. Lipids 41 (2006) 933-935
67. Murphy C.C., Murphy E.J., and Golovko M.Y. Erucic acid is differentially taken up and metabolized in rat liver and heart. Lipids 43 (2008) 391-400
68. Cunnane S.C., Ryan M.A., Nadeau C.R., et al. Why is carbon from some polyunsaturates extensively recycled into lipid synthesis?. Lipids 38 (2003) 477-484
69. Berridge M.J., Downes C.P., and Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59 (1989) 411-419
70. Ding D., and Greenberg M.L. Lithium and valproate decrease the membrane phosphatidylinositol/phosphatidylcholine ratio. Mol. Microbiol. 47 (2003) 373-381
71. Jope R.S., Song L., Li P.P., et al. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem. 66 (1996) 2402-2409
72. O'Donnell T., Rotzinger S., Nakashima T.T., et al. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Res. 880 (2000) 84-91
73. Silverstone P.H., Wu R.H., O'Donnell T., et al. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Hum. Psychopharmacol. 17 (2002) 321-327
74. Frangou S., Lewis M., and McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br. J. Psychiatry 188 (2006) 46-50
75. Frangou S., Lewis M., Wollard J., and Simmons A. Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J. Psychopharmacol. 21 (2007) 435-439
76. Lee H.C., Inoue T., Imae R., et al. Caenorhabditis elegans mboa-7, a member of the MBOAT family, is required for selective incorporation of polyunsaturated fatty acids into phosphatidylinositol. Mol. Biol. Cell 19 (2008) 1174-1184
77. Rumsey S.C., Galeano N.F., Lipschitz B., and Deckelbaum R.J. Oleate and other long chain fatty acids stimulate low density lipoprotein receptor activity by enhancing acyl coenzyme A:cholesterol acyltransferase activity and altering intracellular regulatory cholesterol pools in cultured cells. J. Biol. Chem. 270 (1995) 10008-10016
78. Bazinet R.P., Douglas H., McMillan E.G., Wilkie B.N., and Cunnane S.C. Intramuscular injection of antigens and adjuvant preferentially decreases 18:2n-6 and 18:3n-3 in pig neck muscle. Lipids 38 (2003) 1221-1226
79. Chicco A.J., and Sparagna G.C. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am. J. Physiol. 292 (2007) C33-C44